SCHEMBL4126477

SCHEMBL4126477

CC(C)(C)OC(=O)NC[C@@H]1C[C@H]1c1ccc(-c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.48
KDM1A O60341 1/20 0.40
P2RY14 Q15391 5/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TMEM97 Q5BJF2 2/20 0.39
DRD1 P21728 2/20 0.39
DRD3 P35462 2/20 0.39
TSPO P30536 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
DRD4 P21917 1/20 0.39
DRD5 P21918 1/20 0.39
MAOA P21397 2/20 0.38
MAOB P27338 1/20 0.38
KCNH2 Q12809 1/20 0.38
MDM2 Q00987 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4126474 1.00 HTR2C (0.48) HTR2CKDM1AP2RY14KDM4EALDH1A1
SCHEMBL4138978 0.89 HTR2C (0.43) HTR2CKDM1AP2RY14MAOAMAOB
SCHEMBL4138979 0.89 HTR2C (0.43) HTR2CKDM1AP2RY14MAOAMAOB
SCHEMBL4126563 0.88 SLC6A3 (0.44) HTR2CKDM1APOLBGAAMAOA
SCHEMBL4126559 0.88 SLC6A3 (0.44) HTR2CKDM1APOLBGAAMAOA
SCHEMBL4126113 0.87 CYP17A1 (0.46) KDM1AMAOAMAOB
SCHEMBL4126115 0.87 CYP17A1 (0.46) KDM1AMAOAMAOB
SCHEMBL4133946 0.86 CNR1 (0.49) HTR2CKDM1AALDH1A1GAAMAOA
SCHEMBL4133949 0.86 CNR1 (0.49) HTR2CKDM1AALDH1A1GAAMAOA
SCHEMBL4131945 0.84 HTR2C (0.41) HTR2CGAAMAOAMAOBMDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-08-13 US disclosed
WO-2007025144-A1 5-HT2C RECEPTOR AGONISTS AS ANORECTIC AGENTS UNIVERSITY OF ILLINOIS - CHICAGO (US) 2007-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents HTR2C, HTR2A, HTR5A HTR2C 1/4885KDM1A 3105/4885P2RY14 294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.